Ontology highlight
ABSTRACT: Background
Over 400 million people worldwide are living with a rare disease. Next Generation Sequencing (NGS) identifies potential disease causative genetic variants. However, many are identified as variants of uncertain significance (VUS) and require functional laboratory validation to determine pathogenicity, and this creates major diagnostic delays.Methods
In this study we test a rapid genetic variant assessment pipeline using CRISPR homology directed repair to introduce single nucleotide variants into inducible pluripotent stem cells (iPSCs), followed by neuronal disease modelling, and functional genomics on amplicon and RNA sequencing, to determine cellular changes to support patient diagnosis and identify disease mechanism.Results
As proof-of-principle, we inv
SUBMITTER: Fear VS
PROVIDER: S-EPMC8827184 | biostudies-literature | 2022 Feb
REPOSITORIES: biostudies-literature